Genetics of Cutaneous Malignant Melanoma
Cancer Control, 1995 An increase in the clinical significance of cutaneous malignant melanoma has paralleled a dramatic increase in the rate of death from this disease. The critical genetic changes associated with the genesis and progression of this disease are only beginning to be identified.
, Su, , Trent
openaire +3 more sources
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Biomedicines, 2022 Malignant melanoma is the leading cause of death among cutaneous malignancies. While its incidence is increasing, the most recent cancer statistics show a small but clear decrease in mortality rate.
Madison K Ernst, A. Giubellino
semanticscholar +1 more source
Knockdown of FOXRED2 restrains proliferation, invasion and migration of human melanoma cells
Heliyon, 2023 Objectives: This experiment investigated the role of the FAD-dependent oxidoreductase domain-containing 2 (FOXRED2) in the development of cutaneous malignant melanoma.
Mujin Li +10 more
doaj +1 more source
Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management
World Journal of Oncology, 2021 Cutaneous melanoma (CM) is a malignant tumor formed from pigment-producing cells called melanocytes. It is one of the most aggressive and fatal forms of skin malignancy.
P. Naik
semanticscholar +1 more source
Alcohol drinking, smoking, and cutaneous melanoma risk: Mendelian randomization analysis
Gaceta Sanitaria, 2023 Objective: To investigate the causal relationship between poor lifestyle habits, such as smoking and drinking, and cutaneous malignant melanoma. Method: In the present study, alcohol consumption and smoking were used as exposure factors, and single ...
Jiaxiang Xu +4 more
doaj +1 more source
Incidence and metastasis of cutaneous malignant melanoma with respect to ABO blood groups: a case-controlled study in northeast of China. [PDF]
PLoS ONE, 2014 BACKGROUND: ABO blood groups have been suggested to contribute to the development of certain tumors; however, the associations between ABO blood groups and the incidence and metastases of cutaneous malignant melanomas have not been fully evaluated in ...
Liang Chang +7 more
doaj +1 more source
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
Diagnostics, 2021 Background: The use of 18F-2-Fluor-2-desoxy-D-glucose Positron Emission Tomography/Computed Tomography FDG-PET/CT in clinical routine for staging, treatment response monitoring and post treatment surveillance in metastatic melanoma patients has ...
Ken Kudura +11 more
doaj +1 more source
Kaohsiung Journal of Medical Sciences, 2016 The evidence that PITX1 (pituitary homeobox 1) is a significant tumor suppressor in human cancer remains largely circumstantial, but it clearly warrants further study as little is known about the tumor-inhibitory roles of PITX1 in cutaneous malignant ...
Figen Barut +5 more
doaj +1 more source
Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unit [PDF]
, 2010 Background: malignant melanoma is a rare but potentially lethal form of cancer which may arise on the foot. Evidence suggests that due to misdiagnosis and later recognition, foot melanoma has a poorer prognosis than cutaneous melanoma elsewhere.Methods ...
David AR de Berker +5 more
core +1 more source
‘I am not someone who gets skin cancer’: Risk, time and malignant melanoma [PDF]
, 2013 ‘Delay’ is a term used in the cancer literature since the 1930s to describe the period between self-detection of a concerning sign of possible disease and presentation to a health professional.
Heyman, Bob +5 more
core +1 more source